Surajit Pathak,
Antara Banerjee
Elsevier Science
e druk, 2023
9780443132124
Cancer Stem Cells and Signaling Pathways
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
e druk, 2023
ISBN13: 9780443132124
Rubricering
Levertijd ongeveer 8 werkdagen
Samenvatting
Cancer Stem Cells and Signaling Pathways explores the mechanism of cancer stem cell signaling pathways in cancer advancement, serving as an ideal reference guide for investigators with valuable answers to problems associated with anti-cancer treatments and an understanding of the crosstalk among the signaling pathways in CSC regulation. Despite recent advances in tumor therapy and a greater understanding of their biology, tumors continue to be a prevalent and fatal worldwide. According to a novel paradigm in tumor biology, a small percentage of the cells within a tumor known as cancer stem cells (CSCs) are predicted as a crucial population for tumor progression.
Specificaties
Inhoudsopgave
1. Origin of cancer stem cells (CSCs) and the signalling pathways associated with stem cells and cancer stem cells<br>2. The importance of niche in therapeutic strategies targeting normal and cancer stem cells<br>3. Cancer stem cell research: A phosphoproteomic approach<br>4. Role of Mechanotransduction in stem cells and cancer progression<br>5. Cancer stem cell signaling in neuroblastoma progression- In touch with reality<br>6. Role of cancer stem cells in developing chemoresistance of solid tumor<br>7. The cell surface markers and signaling pathways of cancer stem cells: Target for potent Therapeutics<br>8. Lung cancer stem cells markers and its potential therapeutic molecular targets<br>9. Role of cancer stem cells in maintenance of tumor heterogeneity in brain tumors<br>10. Colorectal cancer stem cells: Overview and potential targeted therapy<br>11. Pancreatic cancer stem cells and inflammation: Milestones achieved and challenges ahead<br>12. Epigenetic modification: Key regulator of reprogramming in cancer stem cells<br>13. Regulation of cancer stemness, cell signaling, reactive oxygen species, and microRNAs in cancer stem cells<br>14. The stem cell niche: Key role on cell therapy in regenerative medicine<br>15. Controlled and targeted proliferation of stem cells for therapeutic application<br>16. MicroRNAs as theranostics: Combating breast cancer stem cells<br>17. Chemical approaches to stem cell and signaling pathways for therapeutics<br>18. Responsive biomimetic nanocarriers and its role in stem cell-based targeting therapeutics<br>19. Stem cell signalling in nephroblastoma with reference to Wilms tumor<br>20. Brain cancer stem cells: Overview and potential targeted therapy<br>21. Pancreatic cancer and stem cell<br>22. Epigenetic modulation of cancer stem cells in vitro 3D models<br>23. Epigenetic signalling: Regulation of cancer stem cells in colorectal cancer<br>24. Cancer stem cells, signalling pathways and chemopreventive effects of phytochemicals in androgen-regulated cancers<br>25. Biomarkers and signalling pathways of esophageal cancer stem cells: promising targets to limit the metastatic potential and stemness.<br>26. miRNA signalling networks of therapeutic interest involved in angiogenesis regulation by cancer stem cells<br>27. An altered metabolic landscape drives quiescence to the reawakening of cancer stem cells.<br>28. Canonical WNT signaling pathway in cancer stem cells and potential inhibitors of therapeutic importance<br>29. A mechanistic view of the role of thyroid cancer stem cells in microenvironment<br>30. Cancer stem cells and maintenance of tumor heterogeneity/microenvironment<br>31. An overview of the role of proto-oncogenes in tissue-specific stem cells<br>32. Components of cancer stem cells microenvironment: Influence on the tumorigenic property and stemness in cancer stem cells.<br>33. An overview of hepatocellular carcinoma stem cells and potential targeted therapies<br>34. Cancer stems cell-derived exosomes: What is known to date<br>35. Signaling mechanisms of chemoresistance in breast cancer stem cells for therapeutics